Developing translational biological psychiatry: learning from history to build the future

  • Konstantin Demin Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg, Russian Federation; Institute of Experimental Medicine, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation; Laboratory of Preclinical Bioscreening, Russian Research Center for Radiology and Surgical Technologies, Pesochny, Russian Federation; Faculty of Biology, Saint Petersburg State University, Saint Petersburg, Russian Federation
  • Darya Meshalkina Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg, Russian Federation; Institute of Experimental Medicine, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation; Laboratory of Preclinical Bioscreening, Russian Research Center for Radiology and Surgical Technologies, Pesochny, Russian Federation
  • Anton Lakstygal Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg, Russian Federation; Faculty of Biology, Saint Petersburg State University, Saint Petersburg, Russian Federation
  • Allan Kalueff Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg, Russian Federation; Institute of Experimental Medicine, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation; Laboratory of Preclinical Bioscreening, Russian Research Center for Radiology and Surgical Technologies, Pesochny, Russian Federation; The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA, USA; Laboratory of Translational Biopsychiatry, Research Institute of Physiology and Basic Medicine, Novosibirsk, Russian Federation; ZENEREI Research Center, Slidell, LA, USA; School of Pharmacy, Southwest University, Chongqing, China; Ural Federal University, Ekaterinburg, Russian Federation


Psychiatric disorders are among the most complex human disorders that, albeit often difficult to diagnose and treat, are widespread in modern society. Biological psychiatry studies biological functions of the central nervous system as mental disorders develop. Today’s biological psychiatry is facing multiple conceptual problems that prevent our deeper understanding of disease pathogenesis and delay the invention of new treatments. Thus, providing a historical context to this rapidly developing field may help scientists better understand the existing challenges and their potential solutions. Here, we discuss the main conceptual problems and paradigms of biological psychiatry, including the lack of reproducibility and/or valid theories, through an historical overview of its role in addressing theoretical and clinical questions. We propose a wider use of the translational approach in psychiatry to expand our analyses of psychiatric disorders to other species, and as a tool to create and further develop theories and concepts in this field.


biological psychiatry, translational medicine, history of psychiatry, modern psychiatry, conceptual issues in psychiatry


Download data is not yet available.


Abrahams, E., and Silver, M. 2010. The history of personalized medicine; pp. 3–16 in: Gordon, E., and Koslow S. (eds.) Integrative neuroscience and personalized medicine. Oxford, New York: Oxford University Press.

Andlauer, O., Lydall, G., Nawka, A., and Guloksuz, S. 2015. Ethical issues of using information technologies in psychiatry: an early career psychiatrists perspective. European Psychiatry 30:38.

Andreasen, N. C. 2004. Brave new brain: Conquering mental illness in the era of the genome. Oxford, New York: Oxford University Press.

Angyal, A. (1948). The holistic approach in psychiatry. American Journal of Psychiatry 105(3): 178–182.

APA. 1960. Diagnostic and Statistical Manual: Mental Disorders:[DSM I]: American Psychiatric Association.

Aragona, M. 2009a. The concept of mental disorder and the DSM-V.

Aragona, M. 2009b. The role of comorbidity in the crisis of the current psychiatric classification system. Philosophy, Psychiatry, and Psychology 16(1):1–11.

Ayd, F., and Healy, D. (1996). The discovery of antidepressants. The Psychopharmacologists. Interviews by David Healy 1:81–110.

Baca-Garcia, E., Perez-Rodriguez, M. M., Basurte-Villamor, I., Del Moral, A. L. F., Jimenez-Arriero, M. A., De Rivera, J. L. G., . . . Oquendo, M. A. (2007). Diagnostic stability of psychiatric disorders in clinical practice. The British Journal of Psychiatry 190(3):210–216.

Baethge, C., Salvatore, P., and Baldessarini, R. J. (2003). “On cyclic insanity” by Karl Ludwig Kahlbaum, MD: a translation and commentary. Harvard review of psychiatry 11(2):78–90.

Beck, A. T. 1979. Cognitive therapy of depression: Guilford press.

Berrios, G. E. 1990. Alzheimer’s disease: A conceptual history. International Journal of Geriatric Psychiatry 5(6):355–365.

Berrios, G. E. 1996. The history of mental symptoms: descriptive psychopathology since the nineteenth century. Cambridge: Cambridge University Press.

Berrios, G. E., and Hauser, R. 1988. The early development of Kraepelin’s ideas on classification: a conceptual history. Psychological medicine 18(4), 813–821.

Berrios, G. E., and Marková, I. S. 2002. Conceptual issues; pp. 1-24 in: D’haenen, H., den Boer, J. A., and Willner, P. Biological psychiatry.

Blair, R. G. 2004. Helping older adolescents search for meaning in depression. Journal of Mental Health Counseling 26(4):333–347.

Boeree, C. G. 2014. Early medicine and physiology. Retrieved from on March, 15.

Bonet, T. 1700. Sepulchretum: sive anatomia practica, ex cadaveribus morbo denatis; proponens historias et observationes omnium pene humani corporis affectuum, ipsorumque causas reconditas revelans; quo nomine tam pathologiae genuinae, quam nosocomiae orthodoxae fundatrix, imo medicinae veteris ac novae promptuarium dici meretur;[4 libris comprehensa and in 2 t. divisa] (Vol. 1): Chouët.

Braff, D. L. 2015. The importance of endophenotypes in schizophrenia research. Schizophrenia Research 163(1–3):1–8.

Burton, R. 1931. The anatomy of melancholy (Vol. 1): G. Routledge.

Cabanis, P. J. G., and Cerise, L. A. P. 1843. Rapports du physique et du moral de l’homme par P.-J.-G. Cabanis: Fortin.

Cade, J. F. 2000. Lithium salts in the treatment of psychotic excitement, 1949. Bulletin of the World Health Organization 78(4):518–520.

Cannon, T. D., and Keller, M. C. 2006. Endophenotypes in the genetic analyses of mental disorders. Annual Review in Clinical Psychology 2:267–290.

Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., . . . Nutt, D. 2014. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in human neuroscience 8(20).

Castro, V. M., Minnier, J., Murphy, S. N., Kohane, I., Churchill, S. E., Gainer, V., . . . International Cohort Collection for Bipolar Disorder, C. 2015. Validation of electronic health record phenotyping of bipolar disorder cases and controls. American Journal of Psychiatry 172(4):363–372.

Ceusters, W., Jensen, M., and Diehl, A. D. 2017. Ontological realism for the research domain Criteria for Mental Disorders. Studies in Health Technology and Informatics 235:431–435.

Charney, D. S., Buxbaum, J. D., Sklar, P., and Nestler, E. J. 2013. Neurobiology of mental illness. Oxford, New York: Oxford University Press.

Chen, Q., Zeng, Z., and Hu, Z. 2012. Optogenetics in neuroscience: what we gain from studies in mammals. Neuroscience Bulletin 28(4):423–434. https://doiorg/10.1007/s12264-012-1250-6

Conry, Y. 1978. Thomas Willis ou le premier discours rationaliste en pathologie mentale. Revue d’histoire des sciences 31(3):193–231.

Costa e Silva, J. A. 2013. Personalized medicine in psychiatry: new technologies and approaches. Metabolism 62(Suppl 1):S40–44.

Coupland, C., Hill, T., Morriss, R., Arthur, A., Moore, M., and Hippisley-Cox, J. 2015. Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. British Medical Journal 350.

Cross-Disorder Group of the Psychiatric Genomics, C. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381(9875):1371–1379.

Cross-Disorder Group of the Psychiatric Genomics, C., Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., . . . International Inflammatory Bowel Disease Genetics, C. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 45(9):984–994.

Crossley, D. R. 2012. Holistic psychiatry without the whole self. The Psychiatrist Online 36(3):97–100.

Cryan, J. F., and Mombereau, C. 2004. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9(4):326–357.

Cuijpers, P., van Straten, A., van Oppen, P., and Andersson, G. 2008. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. Journal of Clinical Psychiatry 69(11):1675–1685.

Cuthbert, B. N., and Insel, T. R. 2010. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophrenia Bulletin 36(6):1061–1062.

D’haenen, H. A., den Boer, J. A., and Willner, P. 2002. Biological psychiatry (Vol. 2). Chichester, UK: Wiley.

Davison, K. 2006. Historical aspects of mood disorders. Psychiatry 5(4):115–118.

Deisseroth, K. 2015. Optogenetics: 10 years of microbial opsins in neuroscience. Nature Neuroscience 18(9):1213–1225.

Ellis, A. 1962. Reason and emotion in psychotherapy. Carol Publishing Group.

Emmert-Streib, F. 2013. Personalized medicine: Has it started yet? A reconstruction of the early history. Frontiers in genetics 3:313.

Fears, S. C., Service, S. K., Kremeyer, B., Araya, C., Araya, X., Bejarano, J., . . . Bearden, C. E. 2014. Multisystem component phenotypes of bipolar disorder for genetic investigations of extended pedigrees. Journal of American Medical Association, Psychiatry 71(4):375–387.

Finger, S. 2000. Chapter 13: Santiago Ramon y Cajal. From nerve nets to neuron doctrine; pp 197-216 in: Minds behind the brain: a history of the pioneers and their discoveries. Oxford: Oxford Scholarships On-line.

Flint, J., and Munafo, M. 2014. Schizophrenia: genesis of a complex disease. Nature 511(7510):412–413.

Francis, T. C., Chaudhury, D., Lobo, M. K. 2014. Optogenetics: illuminating the neural basis of rodent behavior. Open Access Animal Physiology 6:33–51.

Frank, R. G. 1980. Harvey and the Oxford physiologists: a study of scientific ideas: University of California Press. Frankl, V. E. 1976. Man’s search for ultimate meaning; pp. 182–203 in: Needleman, J. and Lewis D. (eds.), On the Way to Self Knowledge. New York.

Freud, S. 1984. Mourning and melancholia (1911). The standard edition of the complete psychological works of Sigmund Freud, 23.

Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., . . . Geschwind, D. H. 2018. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359(6376):693–697.

Garvey, M. A., and Cuthbert, B. N. 2017. Developing a Motor Systems Domain for the NIMH RDoC Program. Schizophrenia Bulletin 43(5):935–936.

Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., . . . Buxbaum, J. D. 2014. Most genetic risk for autism resides with common variation. Nature Genetics 46(8):881–885.

Georget, E. J. 1820. De la folie, considérations sur cette maladie: Chez Crevot.

Gert, B. 1996. Hobbes’s psychology; pp 157-174 in: The Cambridge Companion to Hobbes.

Gillan, C. M., and Whelan, R. 2017. What big data can do for treatment in psychiatry. Current Opinion in Behavioral Sciences 18:34–42.

Glahn, D. C., Curran, J. E., Winkler, A. M., Carless, M. A., Kent, J. W., Jr., Charlesworth, J. C., . . . Blangero, J. 2012. High dimensional endophenotype ranking in the search for major depression risk genes. Biological Psychiatry 71(1):6–14.

Glahn, D. C., Knowles, E. E., McKay, D. R., Sprooten, E., Raventos, H., Blangero, J., . . . Almasy, L. 2014. Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics. American Journal of Medical Genetics, B Neuropsychiatric Genetics 165B(2):122–130.

Gong, Q., and He, Y. 2015. Depression, Neuroimaging and Connectomics: A Selective Overview. Biological psychiatry 77(3):223–235.

Gottesman, II, and Gould, T. D. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160(4):636–645.

Gould, T. D., and Gottesman, II. 2006. Psychiatric endophenotypes and the development of valid animal models. Genes Brain and Behavior 5(2):113–119.

Grether, J. K., Anderson, M. C., Croen, L. A., Smith, D., and Windham, G. C. 2009. Risk of autism and increasing maternal and paternal age in a large north American population. American Journal of Epidemiology 170(9):1118–1126.

Griebel, G., and Holmes, A. 2013. 50 years of hurdles and hope in anxiolytic drug discovery. Nature Reviews Drug Discovery 12(9):667–687.

Harrington, A. 1999. The placebo effect: An interdisciplinary exploration (Vol. 8): Harvard University Press. Harvey, A. G. 2004. Cognitive behavioural processes across psychological disorders: A transdiagnostic approach to research and treatment: Oxford University Press, USA.

Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, II, and Manji, H. K. 2006. Toward constructing an endophenotype strategy for bipolar disorders. Biological Psychiatry 60(2):93–105.

Healy, D. 2001. The antidepressant drama.

Hecker, E., and Kraam, A. 2009. ‘Hebephrenia. A contribution to clinical psychiatry’ by Dr. Ewald Hecker in Gorlitz. 1871. History of psychiatry 20(77 Pt 1):87.

Hegemann, P., and Sigrist, S. 2013. Optogenetics: Walter de Gruyter.

Hippocrates. 2004. Aphorisms: Kessinger Publishing.

Hirshbein, L. 2010. Sex and gender in psychiatry: a view from history. Journal of Medical Humanities 31(2):155–170.

Hobbes, T. 1972. Man and Citizen: De Homine and De Cive: Hackett Publishing.

Hobbes, T., and Macpherson, C. B. 1968. Leviathan; edited with an Introduction by CB Macpherson: Penguin.

Huybrechts, K. F., Schneeweiss, S. , Gerhard, T. , Olfson, M. , Avorn, J. , Levin, R. , Lucas, J. A. and Crystal, S. 2012. Comparative safety of antipsychotic medications in nursing home residents. Journal of American Geriatric Society 60(3):420–429.

Huynh, N. N., and McIntyre, R. S. 2008. What Are the Implications of the STAR*D Trial for primary care? A review and synthesis. Primary Care Companion to the Journal of Clinical Psychiatry 10(2):91–96.

Ikeda, M., Okahisa, Y., Aleksic, B., Won, M., Kondo, N., Naruse, N., . . . Iwata, N. 2013. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology 38(10):1864–1870.

Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., . . . Wang, P. 2010. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 167(7):748–751.

Insel, T. R., and Charney, D. S. 2003. Research on major depression: strategies and priorities. Journal of American Medical Association 289(23):3167–3168.

Ivleva, E. I., Morris, D. W., Moates, A. F., Suppes, T., Thaker, G. K., and Tamminga, C. A. 2010. Genetics and intermediate phenotypes of the schizophrenia–bipolar disorder boundary. Neuroscience Biobehavioral Review 34(6):897–921.

Johnstone, E. C., Crow, T. J., Frith, C. D., Husband, J., and Kreel, L. 1976. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2(7992):924–926.

Kagan, J., Snidman, N., Arcus, D., and Reznick, J. S. 1994. Galen’s prophecy: Temperament in human nature: Basic Books.

Kahlbaum, K. 1973. Catatonia (1874). Translated by Levij Y, Pridan T. Baltimore, MD: Johns Hopkins University Press.

Kahlbaum, K. L. 1863. Die Gruppierung der psychischen Krankheiten und die Eintheilung der Seelenstörungen: Entwurf einer historisch-kritischen Darstellung der bisherigen Eintheilungen und Versuch zur Anbahnung einer empirisch-wissenschaftlichen Grundlage der Psychiatrie als klinischer Disciplin: Kafemann.

Kahlbaum, K. L., and Berrios, G. 1996. Die Gruppirung der psychischen Krankheiten… Part III: (The classification of mental disorders… Part III). History of psychiatry 7(25):167–170.

Kalueff, A. V., Ren-Patterson, R. F., LaPorte, J. L., and Murphy, D. L. 2008. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for highthroughput neurophenotyping research. Behavioral Brain Research 188(2):243–249.

Kalueff, A. V., and Stewart, A. M. 2015. Modeling neuropsychiatric spectra to empower translational biological psychiatry. Behavioral Brain Research 276:1–7.

Kas, M. J., Fernandes, C., Schalkwyk, L. C., and Collier, D. A. 2007. Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men. Molecular Psychiatry 12(4):324–330.

Kato, T. 2009. Epigenomics in psychiatry. Neuropsychobiology 60(1):2–4.

Kato, T. 2011. A renovation of psychiatry is needed. World Psychiatry 10(3):198–199.

Kendell, R., and Jablensky, A. 2003. Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry 160(1):4–12.

Kendler, K. S., and Engstrom, E. J. 2016. Kahlbaum, Hecker, and Kraepelin and the transition from psychiatric symptom complexes to empirical disease forms. American Journal of Psychiatry 174(2):102–109.

Kessler, R. C., Warner, C. H., Ivany, C., Petukhova, M. V., Rose, S., Bromet, E. J., . . . Army, S. C. 2015. Predicting suicides after psychiatric hospitalization in US Army soldiers: the Army Study To Assess Risk and rEsilience in Servicemembers (Army STARRS). Journal of American Medical Association, Psychiatry 72(1):49–57.

Kraam, A. 2004. On the Origin of the Clinical Standpoint in Psychiatry: By Dr Ewald Hecker in Görlitz. History of psychiatry 15(3):345–360.

Kraepelin, E. 1905. Fragestellungen der klinischen Psychiatrie. Cbl. fur Nervenheilk und Psychiatric 8: 573.

Kraepelin, E. 1983. Lebenserinnerungen. Herausgegeben von H. Hippius, G. Pieters, D. Ploog: Berlin: Springer.

Kuhn, R. 1958. The treatment of depressive states with G 22355 (imipramine hydrochloride). American Journal of Psychiatry 115(5):459–464.

Lanczik, M. 1988. Der Breslauer Psychiater Carl Wernicke. Werkanalyse und Wirkungsgeschichte als Beitrag zur Medizingeschichte Schlesiens (Sigmaringen: Thorbecke).

Lapin, I., and Oxenkrug, G. 1969. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. The Lancet 293(7586):132–136.

LaPorte, J. L., Egan, R. J., Hart, P. C., Bergner, C. L., Cachat, J. M., Canavello, P. R., and Kalueff, A. V. 2010. Qui non proficit, deficit: experimental models for ‘integrative’ research of affective disorders. Journal of Affective Disorders 121(1–2):1–9.

Lee, R., and Avramopoulos, D. 2014. Chapter 1 — Introduction to Epigenetics in Psychiatry; pp. 3–25 in: Epigenetics in Psychiatry. Boston: Academic Press.

Lewis, A. J. 1934. Melancholia: a clinical study of depressive states. Journal of Mental Science 80:277–378.

Lindemann, M. 2010. Medicine and society in early modern Europe: Cambridge University Press.

Linden, D. E. 2012. The challenges and promise of neuroimaging in psychiatry. Neuron 73(1):8–22.

Linden, D. E., and Fallgatter, A. J. 2009. Neuroimaging in psychiatry: from bench to bedside. Frontiers in Human Neuroscience 3:49.

Linnett, P. 2006. Making connections: towards a holistic psychiatry. Spirituality and Health International 7(1):40–47.

Lloyd, G. 1983. Introduction to Hippocratic Writings. Translated by J. Chadwick and WN Mann: Harmondsworth, UK: Penguin.

López-Muñoz, F., Alamo, C., Cuenca, E., Shen, W. W., Clervoy, P., and Rubio, G. 2005. History of the discovery and clinical introduction of chlorpromazine. Annals of Clinical Psychiatry 17(3):113–135.

López-Munoz, F., Alamo, C., Juckel, G., and Assion, H.-J. 2007. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors. Journal of Clinical Psychopharmacology 27(6):555–559.

Lutz, P. L. 2002. The rise of experimental biology: an illustrated history: Springer Science and Business Media.

Ma, L., Demin, K. A., Kolesnikova, T. O., Kharsko, S. L., Zhu, X., Yuan, X., . . . Kalueff, A. V. 2017. Animal inflammation-based models of depression and their application to drug discovery. Expert Opinion on Drug Discovery 12(10):995–1009.

Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., and Jerabek, P. A. 2002. The functional neuroanatomy of the placebo effect. American Journal of Psychiatry 159(5):728–737.

McHugh, P., and Slavney, P. 1998. The Perspectives of Psychiatry. Baltimore and London: Johns Hopkins University Press.

McMahon, F. J., and Insel, T. R. 2012. Pharmacogenomics and personalized medicine in neuropsychiatry. Neuron 74(5):773–776.

Meyer-Lindenberg, A., and Weinberger, D. R. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience 7(10):818–827.

Meynert, T. 1885. Psychiatry: Clinical treatise on the diseases of the fore-brain. New York and London: GP Putnam.

Misgeld, T., and Kerschensteiner, M. 2006. In vivo imaging of the diseased nervous system. Nature Review Neuroscience 7(6):449–463.

Moerman, D. E. 2002. Meaning, Medicine, and the” placebo Effect” (Vol. 28). Cambridge: Cambridge University Press.

Monteith, S., Glenn, T., Geddes, J., and Bauer, M. 2015. Big data are coming to psychiatry: a general introduction. International Journal of Bipolar Disorder 3(1):21.

Morgagni, G. 1769. The seats and causes of diseases investigated by anatomy; in five books, containing a great variety of dissections, with remarks. To which are added very accurate and copious indexes of the principal things and names therein contained. Vol. 2. London, Printed for A. Millar, and T. Cadell, his successor [etc.].

Murad, I., and Gordon, H. 2002. Psychiatry and the Palestinian population. The Psychiatrist 26(1):28–30.

Murphy, D. L., Uhl, G. R., Holmes, A., Ren-Patterson, R., Hall, F. S., Sora, I., Detera-Wadleigh, S., Lesch, K. P. 2003. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain and Behavior 2(6):350–364.

Murray, C. J., and Lopez, A. D. 1997. Alternative projections of mortality and disability by cause 1990–2020: Global burden of disease study. Lancet 349(9064): 1498–1504.

Muskin, P. R. 2008. Complementary and alternative medicine and psychiatry. American Psychiatric Pub.

Nestler, E. J., and Hyman, S. E. 2010. Animal models of neuropsychiatric disorders. Nature Neuroscience 13(10):1161–1169.

Nissim-Sabat, M. 2013. Race and gender in philosophy of psychiatry: Science, relativism, and phenomenology; pp. 139-158 in: Fulford, K. W. M., Davies, M., Gipps, R. G. T., Graham, G., Sadler, J. Z., Stanghellini, G., and Thornton, T. (eds.) The Oxford Handbook of Philosophy and Psychiatry.

Orlovska, S., Pedersen, M. S., Benros, M. E., Mortensen, P. B., Agerbo, E., and Nordentoft, M. 2014. Head injury as risk factor for psychiatric disorders: a nationwide registerbased follow-up study of 113,906 persons with head injury. American Journal of Psychiatry 171(4):463–469.

Ozomaro, U., Wahlestedt, C., and Nemeroff, C. B. 2013. Personalized medicine in psychiatry: problems and promises. BMC Medicine 11:132.

Panksepp, J. 2004a. Affective neuroscience: The foundations of human and animal emotions. Oxford University Press.

Panksepp, J. 2004b. Biological psychiatry sketched — past, present, and future; pp. 3–32 in: Textbook of biological psychiatry.

Panksepp, J. 2004c. Textbook of biological psychiatry. John Wiley and Sons.

Peedicayil, J., Grayson, D. R., and Avramopoulos, D. 2014. Epigenetics in psychiatry. Elsevier.

Perlis, R. H., Iosifescu, D. V., Castro, V. M., Murphy, S. N., Gainer, V. S., Minnier, J., … Smoller, J. W. 2012. Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychological Medicine 42(1):41–50.

Petrovic, P., Kalso, E., Petersson, K. M., and Ingvar, M. 2002. Placebo and opioid analgesia–imaging a shared neuronal network. Science 295(5560):1737–1740.

Pincus, H. A., Zarin, D. A., and First, M. 1998. Clinical significance and DSM-IV. Archives of general psychiatry 55(12):1145.

Porter, R. 1988. Dizionario biografico della storia della medicina e delle scienze naturali (liber amicorum).

Preston, J., O’Neal, J. H., and Talaga, M. C. 2010. Handbook of clinical psychopharmacology for therapists. New Harbinger Publications.

Radden, J. 2003. Is This Dame Melancholy?: Equating today’s depression and past melancholia. Philosophy, Psychiatry, and Psychology 10(1):37–52.

Roach, I. H., Bronner, F., and Oreffo, R. 2011. Epigenetic Aspects of Chronic Diseases. Springer.

Robitzek, E. H., Selikoff, I. J., Mamlok, E., and Tendlau, A. 1953. Isoniazid and its isopropyl derivative in the therapy of tuberculosis in humans: comparative therapeutic and toxicologic properties. Diseases of the Chest 23(1):1–15.

Schildkraut, J. J. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry 122(5):509–522.

Schizophrenia Working Group of the Psychiatric Genomics, C. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421–427.

Schmidt, M. V., Wang, X. D., and Meijer, O. C. 2011. Early life stress paradigms in rodents: potential animal models of depression? Psychopharmacology (Berl) 214(1):131–140.

Scholl, R. 2002. Der Papyrus Ebers: die grösste Buchrolle zur Heilkunde Altägyptens (Vol. 7): (Schriften aus der Universitätsbibliothek Leipzig) Taschenbuch — 1.

Seidner, S. S. 2009. A Trojan Horse: Logotherapeutic transcendence and its secular implications for theology. Mater Dei Institute 10–12.

Selikoff, I. J., and Robitzek, E. H. 1952. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Diseases of the Chest 21(4):385–438.

Shapiro, A. K., and Shapiro, E. 2000. The powerful placebo: From ancient priest to modern physician. JHU Press. Solms, M., and Turnbull, O. 2002. The brain and the inner world: An introduction to the neuroscience of subjective experience. Karnac Books.

Spiegel, R. 2003. Psychopharmacology: an introduction. John Wiley and Sons.

Stein, D. J., and Ludik, J. 1998. Neural networks and psychopathology: Connectionist models in practice and research. Cambridge: Cambridge University Press.

Stone, M. H. 1997. Healing the mind: A history of psychiatry from antiquity to the present. WW Norton and Company.

Sudhoff, K., and Garrison, F. H. 1926. Essays in the History of Medicine. New York: Medical Life Press.

Swendsen, J., and Salamon, R. 2012. Mobile technologies in psychiatry: providing new perspectives from biology to culture. World Psychiatry 11(3):196–198.

Tsankova, N., Renthal, W., Kumar, A., and Nestler, E. J. 2007. Epigenetic regulation in psychiatric disorders. Nature Reviews Neuroscince 8(5):355–367.

Uddin, M., Tammimies, K., Pellecchia, G., Alipanahi, B., Hu, P., Wang, Z., … Scherer, S. W. 2014. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nature Genetics 46(7):742–747.

Valenstein, E. S. 1974. Brain control: A critical examination of brain stimulation and psychosurgery. John Wiley and Sons.

Valuck, R. J., Anderson, H. O., Libby, A. M., Brandt, E., Bryan, C., Allen, R. R., … Pace, W. D. 2012. Enhancing electronic health record measurement of depression severity and suicide ideation: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. The Journal of the American Board of Family Medicine 25(5):582–593.

Van Sertima, I. 1992. Golden age of the Moor. (series Journal of African Civilizations 11). New Brunswick, U. S. A.: Transaction Publishers.

von Monakow, C., and Mourgue, R. 1928. Introduction biologique à l’étude de la neurologie et de la psychopathologie: intégration et désintégration de la fonction. F. Alcan.

Vora, E., Aloysi, A., and Zhuk, R. 2017. Complementary and Alternative Medicine; pp 383–387 in Psychiatry. Mount Sinai Expert Guides.

Wallace, E. R. 2008. Two “mind”-“body” models for a holistic psychiatry; pp. 695–723 in History of psychiatry and medical psychology. Springer.

Wassmann, C. 2010. Reflections on the “body loop”: Carl Georg Lange’s theory of emotion. Cognition and Emotion 24(6):974–990.

Wernicke, C. 1906. Grundriss der Psychiatrie in klinischen Vorlesungen. Thieme.

Wickens, A. P. 2014. A history of the brain: from stone age surgery to modern neuroscience. Hove, UK: Psychology Press.

Willis, T., and Guidott, T. 1992. The London practice of physick. Classics of Medicine Library.

Wong, M. L., and Licinio, J. 2004. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nature Reviews Drug Discovery 3(2):136–151.

Wray, N. R., Lee, S. H., Mehta, D., Vinkhuyzen, A. A., Dudbridge, F., and Middeldorp, C. M. 2014. Research review: Polygenic methods and their application to psychiatric traits. J Child Psychology and Psychiatry 55(10): 1068–1087.

Wu, L. T., Gersing, K. R., Swartz, M. S., Burchett, B., Li, T. K., and Blazer, D. G. 2013. Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. Journal of Psychiatric Research 47(4): 555–563.

Yasui, D., Peedicayil, J., and Grayson, D. R. 2016. Neuropsychiatric Disorders and Epigenetics. Academic Press.

Yizhar, O., Fenno, L. E., Davidson, T. J., Mogri, M., and Deisseroth, K. 2011. Optogenetics in neural systems. Neuron 71(1):9–34.

Zeng, H., and Madisen, L. 2012. Mouse transgenic approaches in optogenetics. Progress in Brain Research 196:193–213.
How to Cite
Demin, K., Meshalkina, D., Lakstygal, A., & Kalueff, A. (2018). Developing translational biological psychiatry: learning from history to build the future. Biological Communications, 62(4), 278–292.
Review communications